A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V
- PMID: 22863190
- PMCID: PMC3415533
- DOI: 10.1016/j.ajhg.2012.06.005
A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V
Abstract
Osteogenesis imperfecta (OI) is a heterogenous group of genetic disorders of bone fragility. OI type V is an autosomal-dominant disease characterized by calcification of the forearm interosseous membrane, radial head dislocation, a subphyseal metaphyseal radiodense line, and hyperplastic callus formation; the causative mutation involved in this disease has not been discovered yet. Using linkage analysis in a four-generation family and whole-exome sequencing, we identified a heterozygous mutation of c.-14C>T in the 5'-untranslated region of a gene encoding interferon-induced transmembrane protein 5 (IFITM5). It completely cosegregated with the disease in three families and occurred de novo in five simplex individuals. Transfection of wild-type and mutant IFITM5 constructs revealed that the mutation added five amino acids (Met-Ala-Leu-Glu-Pro) to the N terminus of IFITM5. Given that IFITM5 expression and protein localization is restricted to the skeletal tissue and IFITM5 involvement in bone formation, we conclude that this recurrent mutation would have a specific effect on IFITM5 function and thus cause OI type V.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.Am J Hum Genet. 2012 Aug 10;91(2):349-57. doi: 10.1016/j.ajhg.2012.06.011. Epub 2012 Aug 2. Am J Hum Genet. 2012. PMID: 22863195 Free PMC article.
-
The IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V.BMC Musculoskelet Disord. 2014 Mar 27;15:107. doi: 10.1186/1471-2474-15-107. BMC Musculoskelet Disord. 2014. PMID: 24674092 Free PMC article.
-
Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.J Bone Miner Res. 2013 Nov;28(11):2333-7. doi: 10.1002/jbmr.1983. J Bone Miner Res. 2013. PMID: 23674381 Free PMC article.
-
IFITM5 mutations and osteogenesis imperfecta.J Bone Miner Metab. 2016 Mar;34(2):123-31. doi: 10.1007/s00774-015-0667-1. Epub 2015 Jun 2. J Bone Miner Metab. 2016. PMID: 26031935 Review.
-
A novel Ser40Trp variant in IFITM5 in a family with osteogenesis imperfecta and review of the literature.Clin Dysmorphol. 2019 Jul;28(3):120-125. doi: 10.1097/MCD.0000000000000279. Clin Dysmorphol. 2019. PMID: 30985308 Review.
Cited by
-
"Unveiling the genetic symphony: Diversity and expression of chicken IFITM genes in Aseel and Kadaknath breeds".Heliyon. 2024 Sep 10;10(18):e37729. doi: 10.1016/j.heliyon.2024.e37729. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39315180 Free PMC article.
-
Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta.Calcif Tissue Int. 2024 Sep 4. doi: 10.1007/s00223-024-01263-8. Online ahead of print. Calcif Tissue Int. 2024. PMID: 39231826 Review.
-
Update on the Genetics of Osteogenesis Imperfecta.Calcif Tissue Int. 2024 Aug 11. doi: 10.1007/s00223-024-01266-5. Online ahead of print. Calcif Tissue Int. 2024. PMID: 39127989 Review.
-
Pathological autoantibody internalisation in myositis.Ann Rheum Dis. 2024 Oct 21;83(11):1549-1560. doi: 10.1136/ard-2024-225773. Ann Rheum Dis. 2024. PMID: 38902010
-
The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect.J Clin Invest. 2024 Jun 17;134(15):e170369. doi: 10.1172/JCI170369. J Clin Invest. 2024. PMID: 38885336 Free PMC article.
References
-
- Rauch F., Glorieux F.H. Osteogenesis imperfecta. Lancet. 2004;363:1377–1385. - PubMed
-
- Morello R., Bertin T.K., Chen Y., Hicks J., Tonachini L., Monticone M., Castagnola P., Rauch F., Glorieux F.H., Vranka J. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell. 2006;127:291–304. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
